Tessema FA - Search Results

1

US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate.

Rome BN, Tessema FA, Kesselheim AS. Rome BN, et al. Among authors: tessema fa. JAMA Intern Med. 2020 Sep 1;180(9):1165-1172. doi: 10.1001/jamainternmed.2020.2771. JAMA Intern Med. 2020. PMID: 32897384 Free PMC article.

2

Internal Medicine Physicians' Financial Relationships with Industry: An Updated National Estimate.

Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM. Kesselheim AS, et al. Among authors: tessema fa. J Gen Intern Med. 2019 Feb;34(2):195-197. doi: 10.1007/s11606-018-4688-z. J Gen Intern Med. 2019. PMID: 30291605 Free PMC article. No abstract available.

3

Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.

Kesselheim AS, Woloshin S, Lu Z, Tessema FA, Ross KM, Schwartz LM. Kesselheim AS, et al. Among authors: tessema fa. JAMA Intern Med. 2019 May 1;179(5):707-709. doi: 10.1001/jamainternmed.2018.8121. JAMA Intern Med. 2019. PMID: 30667474 Free PMC article.

4

Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis.

Gyawali B, Tessema FA, Jung EH, Kesselheim AS. Gyawali B, et al. Among authors: tessema fa. JAMA Netw Open. 2019 Aug 2;2(8):e199570. doi: 10.1001/jamanetworkopen.2019.9570. JAMA Netw Open. 2019. PMID: 31469391 Free PMC article.

5

Challenges and Opportunities for Biomarker Validation.

Hey SP, D'Andrea E, Jung EH, Tessema F, Luo J, Gyawali B, Kesselheim AS. Hey SP, et al. J Law Med Ethics. 2019 Sep;47(3):357-361. doi: 10.1177/1073110519876162. J Law Med Ethics. 2019. PMID: 31560620

6

Patients' Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey.

Kesselheim AS, Sinha MS, Rausch P, Lu Z, Tessema FA, Lappin BM, Zhou EH, Dal Pan GJ, Zwanziger L, Ramanadham A, Loughlin A, Enger C, Avorn J, Campbell EG. Kesselheim AS, et al. Among authors: tessema fa. J Law Med Ethics. 2019 Sep;47(3):430-441. doi: 10.1177/1073110519876176. J Law Med Ethics. 2019. PMID: 31560634

7

Physician Perceptions of Step Therapy Prescribing Requirements.

Fischer MA, Kesselheim AS, Lu Z, Ross KM, Tessema FA, Avorn J. Fischer MA, et al. Among authors: tessema fa. J Manag Care Spec Pharm. 2019 Nov;25(11):1210-1224. doi: 10.18553/jmcp.2019.25.11.1210. J Manag Care Spec Pharm. 2019. PMID: 31663459 Free PMC article.

8

Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.

Schwartz LM, Woloshin S, Lu Z, Ross KM, Tessema FA, Peter D, Kesselheim AS. Schwartz LM, et al. Among authors: tessema fa. Circ Cardiovasc Qual Outcomes. 2019 Nov;12(11):e006073. doi: 10.1161/CIRCOUTCOMES.119.006073. Epub 2019 Nov 11. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31707825 Clinical Trial.

9

Public funding for transformative drugs: the case of sofosbuvir.

Barenie RE, Avorn J, Tessema FA, Kesselheim AS. Barenie RE, et al. Among authors: tessema fa. Drug Discov Today. 2021 Jan;26(1):273-281. doi: 10.1016/j.drudis.2020.09.024. Epub 2020 Oct 1. Drug Discov Today. 2021. PMID: 33011345 Free PMC article. Review.

10

Changes in Erythropoiesis Stimulating Agent Use Under a Risk Evaluation and Mitigation Strategy (REMS) Program.

Sarpatwari A, He M, Tessema FA, Gagne JJ, Kesselheim AS. Sarpatwari A, et al. Among authors: tessema fa. Drug Saf. 2021 Mar;44(3):327-335. doi: 10.1007/s40264-020-01017-z. Epub 2020 Nov 18. Drug Saf. 2021. PMID: 33206339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page